dr. venook discusses implications of the calgb/swog 80405 study
Published 10 years ago • 194 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:07
dr. venook discusses the results of the 80405 trial
-
1:38
alan venook, md explains the outcome of phase 3 calgb/swog 80405 study
-
8:41
calgb 80405 trial results in metastatic colorectal cancer
-
7:46
a closer look at fire-3 and calgb/swog 80405
-
1:59
dr. venook on evolving treatment strategies in crc
-
18:40
molecular classification of colon cancer: new insights
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
37:43
solchan won: bacterial evs in cancer immunotherapy
-
1:23
dr. venook on immunotherapy potential in colorectal cancer
-
11:07
future analyses from the 80405 metastatic colorectal cancer trial
-
26:20
colorectal cancer: the link between the immune microenvironment and outcomes
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
4:13
a closer look at tumor location analyses in colon cancer
-
0:36
advances in the treatment of pancreatic cancer
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
0:42
evaluating patient suitability for zolbetuximab in gastroesophageal cancer
-
3:03
personalized medicine in colorectal cancer
-
0:47
phase ii giant trial insights: managing older adults with metastatic pancreatic cancer
-
1:05
swog s1512: pembrolizumab in desmoplastic melanoma
-
1:08
nest-1: neoadjuvant botensilimab and balstilimab in colorectal cancer
-
2:23
biomarker testing and targeted therapies in colorectal cancer
-
0:40
combining immunotherapy and chemotherapy in rectal cancer